Bora Pharmaceuticals Co. Ltd (BORAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | 113,447 | 154,100 |
| Depreciation Amortization | 34,879 | 31,919 |
| Accounts receivable | 44,566 | -53,092 |
| Accounts payable and accrued liabilities | 4,503 | -20,635 |
| Other Working Capital | 70,220 | -89,044 |
| Other Operating Activity | -123,049 | 7,256 |
| Operating Cash Flow | $144,565 | $30,503 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -35,057 | 7,808 |
| PPE Investments | -21,268 | -13,238 |
| Net Acquisitions | -19,909 | -319,861 |
| Purchase Sale Intangibles | -1,412 | -4,943 |
| Other Investing Activity | -32,253 | -6,869 |
| Investing Cash Flow | $-108,487 | $-332,160 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 43,971 | 56,714 |
| Debt Issued | 14,766 | 467,138 |
| Debt Repayment | -42,120 | -87,244 |
| Common Stock Repurchased | -3,206 | -12,102 |
| Other Financing Activity | -57,610 | -49,111 |
| Financing Cash Flow | $-44,199 | $375,396 |
| Exchange Rate Effect | -16,029 | 12,591 |
| Beginning Cash Position | 187,117 | 94,957 |
| End Cash Position | 162,968 | 181,288 |
| Net Cash Flow | $-24,149 | $86,331 |
| Free Cash Flow | ||
| Operating Cash Flow | 144,565 | 30,503 |
| Capital Expenditure | -21,464 | -13,630 |
| Free Cash Flow | 123,101 | 16,874 |